Skip to main content
Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.23
-6.26 (-23.63%)
At close: Feb 27, 2026, 4:00 PM EST
20.63
+0.40 (1.98%)
After-hours: Feb 27, 2026, 7:56 PM EST

Amphastar Pharmaceuticals Revenue

In the year 2025, Amphastar Pharmaceuticals had annual revenue of $719.89M, down -1.65%. Amphastar Pharmaceuticals had revenue of $183.11M in the quarter ending December 31, 2025, a decrease of -1.83%.

Revenue (ttm)
$719.89M
Revenue Growth
-1.65%
P/S Ratio
1.28
Revenue / Employee
$354,974
Employees
2,028
Market Cap
923.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025719.89M-12.08M-1.65%
Dec 31, 2024731.97M87.57M13.59%
Dec 31, 2023644.40M145.41M29.14%
Dec 31, 2022498.99M61.22M13.98%
Dec 31, 2021437.77M87.92M25.13%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Evotec SE 887.40M
ANI Pharmaceuticals 883.37M
Tilray Brands 837.32M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Alvotech 573.35M
Esperion Therapeutics 303.80M
Ironwood Pharmaceuticals 296.15M
Revenue Rankings

AMPH News

More News